Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current Development
Urothelial carcinoma (UC) is the most common histological subtype of bladder tumors; however, bladder cancer represents a heterogeneous group of diseases with at least 40 distinct histological subtypes. Among these, the 2022 World Health Organization classification of urinary tract tumors identifies...
Saved in:
| Main Authors: | Whi-An Kwon, Ho Kyung Seo, Geehyun Song, Min-Kyung Lee, Weon Seo Park |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/1/86 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladder
by: Natalia Gorbokon, et al.
Published: (2025-07-01) -
First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure
by: Bożena Sikora-Kupis, et al.
Published: (2024-01-01) -
The role of circulating tumor DNA (ctDNA) in urothelial cancers
by: Jeanny B. Aragon-Ching
Published: (2025-05-01) -
Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer
by: Shuo Wang, et al.
Published: (2024-11-01) -
Case Report: Alpha-fetoprotein-producing urothelial carcinoma of the bladder
by: Haibing Huang, et al.
Published: (2025-05-01)